The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Massey, W. A.
Right arrow Articles by Lichtenstein, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Massey, W. A.
Right arrow Articles by Lichtenstein, L. M.

The Journal of Immunology, Vol 147, Issue 5 1621-1627, Copyright © 1991 by American Association of Immunologists


ARTICLES

Human uterine mast cells. Isolation, purification, characterization, ultrastructure, and pharmacology

WA Massey, CB Guo, AM Dvorak, WC Hubbard, BS Bhagavan, VL Cohan, JA Warner, A Kagey-Sobotka and LM Lichtenstein
Department of Medicine, Johns Hopkins University, School of Medicine, Baltimore, MD 21224.

As part of an ongoing investigation of human mast cell heterogeneity, we have isolated, partially purified, and characterized the uterine mast cell and compared it with mast cells isolated from other organs. The average histamine content of myometrium and leiomyofibroma obtained from hysterectomies was 2.1 +/- 0.3 (mean +/- SEM) microgram/g of tissue (n = 10), and the histamine content of the two tissues did not differ significantly. A mild collagenase, hyaluronidase, and DNase digestion was used to disperse the uterine mast cells, with an average yield of 9.5% (range, 0 to 21%). The average histamine/uterine mast cell was 2.1 +/- 0.2 pg (n = 3), and 61 +/- 7% (n= 3) of the uterine mast cells survived overnight culture. Early purification efforts with Percoll gradients have yielded up to 80% pure uterine mast cells, with an average of 27 +/- 10% (n = 5). Uterine mast cells released histamine in response to the secretogogues anti-IgE and A23187 but did not respond to substance P or to the basophil secretogogues FMLP, C5a, and 12-O-tetradecanoylphorbol-13-acetate. After 1 microgram/ml anti-IgE stimulation, the uterine mast cell appeared to make significant quantities of PGD2 (89 +/- 26 ng/10(6) cells, n = 6) (p less than 0.05), as assayed by RIA. Simultaneously, leukotriene C4 release was 45 +/- 15 ng/10(6) cells, (n = 6) (p less than 0.05), as assayed by RIA. Combined gas-chromatography mass spectroscopy analysis of anti-IgE- stimulated cell supernatants confirmed the production of PGD2. In pharmacologic studies, isobutyl-methylxanthine and isoproterenol blocked anti-IgE-induced histamine release. The uterine mast cell is similar to the lung mast cell in terms of response to secretogogues and release of arachidonic acid metabolites. Ultrastructurally, the uterine mast cell contains scroll granules, crystal granules, combined granules, homogeneously dense granules, and large lipid bodies, many with focal lucencies within them. Particle granules, most frequently present in gut mast cells of mucosal origin, were absent from uterine mast cells. Although certain features are analogous to the ultrastructure of skin or lung mast cells, the combination of structures is distinctive for uterine mast cells.


This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
J. M. Willets, A. H. Taylor, H. Shaw, J. C. Konje, and R. A. J. Challiss
Selective Regulation of H1 Histamine Receptor Signaling by G Protein-Coupled Receptor Kinase 2 in Uterine Smooth Muscle Cells
Mol. Endocrinol., August 1, 2008; 22(8): 1893 - 1907.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
L. Maintz, V. Schwarzer, T. Bieber, K. van der Ven, and N. Novak
Effects of histamine and diamine oxidase activities on pregnancy: a critical review
Hum. Reprod. Update, May 22, 2008; (2008) dmn014v1.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
J. N. Pennefather, E. Patak, S. Ziccone, A. Lilley, F. M. Pinto, N. M. Page, M. E. Story, S. Grover, and M. L. Candenas
Regulation of the Stimulant Actions of Neurokinin A and Human Hemokinin-1 on the Human Uterus: A Comparison with Histamine
Biol Reprod, September 1, 2006; 75(3): 334 - 341.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
L. B. Corbeil, C. M. Campero, J. C. Rhyan, M. L. Anderson, L. J. Gershwin, D. W. Agnew, L. Munson, and R. H. BonDurant
Uterine Mast Cells and Immunoglobulin-E Antibody Responses During Clearance of Tritrichomonas foetus
Vet. Pathol., May 1, 2005; 42(3): 282 - 290.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
F. H. Hsieh, B. K. Lam, J. F. Penrose, K. F. Austen, and J. A. Boyce
T Helper Cell Type 2 Cytokines Coordinately Regulate Immunoglobulin E-dependent Cysteinyl Leukotriene Production by Human Cord Blood-derived Mast Cells: Profound Induction of Leukotriene C4 Synthase Expression by Interleukin 4
J. Exp. Med., January 2, 2001; 193(1): 123 - 134.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H.-J. Buhring, P. J. Simmons, M. Pudney, R. Muller, D. Jarrossay, A. van Agthoven, M. Willheim, W. Brugger, P. Valent, and L. Kanz
The Monoclonal Antibody 97A6 Defines a Novel Surface Antigen Expressed on Human Basophils and Their Multipotent and Unipotent Progenitors
Blood, October 1, 1999; 94(7): 2343 - 2356.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1991 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1991 by The American Association of Immunologists, Inc. All rights reserved.